Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Spexis AG
SPEXCurrent price
0.02 CHF
-0.03 CHF (-60.00%)
Last closed
0.05 CHF
Company
spexisbio.com
ISIN
CH0106213793
Sector
Healthcare
Industry
Biotechnology
Exchange
SIX Swiss Exchange
Capitalization
3 892 360 CHF
Yield for 12 month
-74.94 %
1Y
3Y
5Y
10Y
15Y
SPEX
Spexis AG, a clinical-stage biopharmaceutical company, engages in discovering, developing, in-licensing, and acquiring molecules for rare diseases and cancer. Its products pipeline includes ColiFin, an inhaled colistimethate sodium product that is in the phase 3 trial for the treatment of cystic fibrosis (CF) infections; Inhaled Murepavadin, a novel class inhaled antibiotic which is in the phase 1 development stage to treat Pseudomonas aeruginosa infection in people with CF; EBX-002 for non-tuberculous mycobacterial lung infections; Balixafortide for oncology and non-oncology indications; New CXCR4 for treating orphan and hematological malignancies, and non-oncology indications; and Outer Membrane Protein Targeting Antibiotic BamA and lipopolysaccharide transport protein A programs. Spexis AG is headquartered in Allschwil, Switzerland. Address: Hegenheimermattweg 125, Allschwil, Switzerland, 4123
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.57 CHFP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures SPEX
1 year
3 years
5 years
10 years
EBITDA
-20 547 150 CHF
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-54.97 %
PEG Ratio
–
Return On Equity TTM
-180.9 %
Wall Street Target Price
1.57 CHF
Revenue TTM
600 827 CHF
Book Value
0.039 CHF
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-62.1 %
Dividend Yield
–
Gross Profit TTM
1 488 703 CHF
Earnings per share
-0.22 CHF
Diluted Eps TTM
-0.22 CHF
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics SPEX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SPEX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation SPEX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
6.4783
Enterprise Value EBITDA
-0.8034
Price Book MRQ
1.4788
Financials SPEX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators SPEX
For 52 weeks
0.01 CHF
0.7 CHF
50 Day MA
0.049 CHF
Shares Short Prior Month
–
200 Day MA
0.087 CHF
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart